Colon tumor formation affected by genetic modifier
10/02/2014
Unexpected results from an ongoing experiment in the lab of Kristi Neufeld, co-leader of the Cancer Biology Program at the University of Kansas Cancer Center, led to a potentially important discovery...
Boosting the power of brain tumor treatments with transplant drug
10/02/2014
Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts.
Trastuzumab should remain as standard of care for HER2-positive breast cancer
10/02/2014
Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that...
Breast cancer: are men the forgotten victims?
10/01/2014
In the US, 2,360 men will be diagnosed with breast cancer this year. But still, many people believe that it only affects women. We investigate the reasons why.
Genetic test would help 'cut bowel cancer spread'
10/01/2014
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found.
Study: tumor BRACAnalysis CDx identifies 44 percent more candidates for PARP therapy
10/01/2014
Myriad Genetics, Inc. has announced that its Tumor BRACAnalysis CDx™ companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in women...
GSK has announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.
GSK has announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.
Genetic test would help 'cut bowel cancer spread'
10/01/2014
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found.
Targeted treatment could halt womb cancer growth
10/01/2014
A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer.